$42,990,046

Supports the Vanderbilt Vaccine and Treatment Evaluation Unit to conduct vaccine and treatment research and evaluation activities.

Academic vaccine evaluation capacity strengthens U.S. pandemic preparedness and accelerates vaccine development pipelines for emerging infectious diseases.

Academic evaluation infrastructure supports vaccine manufacturers and regulators with critical efficacy and safety data for vaccine development and approval pipelines.

Strong vaccine evaluation capacity enhances U.S. competitive position in pandemic preparedness and global vaccine development leadership against international competitors.